Marker Therapeutics, Inc. (MRKR) Financials
MRKR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 19.5 million | 2.8 million |
| 2023-06-30 | 22.0 million | 2.9 million |
| 2023-03-31 | 27.9 million | 12.0 million |
| 2022-12-31 | 34.4 million | 14.8 million |
MRKR Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -1.1 million | 175041 |
| 2023-06-30 | -6.9 million | -120055 |
| 2023-03-31 | -6.0 million | 659913 |
| 2022-12-31 | -6.4 million | 717173 |
MRKR Net Income
No data available :(
MRKR Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 17.5 million | - | - |
| 2023-06-30 | 18.1 million | - | - |
| 2023-03-31 | 6.4 million | - | 7.5 million |
| 2022-12-31 | 11.8 million | - | 7.6 million |
MRKR Shares Outstanding
MRKR Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | - | 2.0 million | 1.4 million | - |
| 2023-06-30 | 112608 | 2.4 million | 2.5 million | - |
| 2023-03-31 | 112608 | 7.3 million | 2.5 million | - |
| 2022-12-31 | 127342 | 5.3 million | 1.9 million | - |
MRKR Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | 257606 | - |
| 2023-06-30 | 762658 | 2.4 million |
| 2023-03-31 | 3.5 million | 3.4 million |
| 2022-12-31 | 6.1 million | 965007 |
MRKR
Price: $4.14
52 week price:
Earnings Per Share: -1.59 USD
P/E Ratio: -1.43
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 156064
Market Capitalization: 37.6 million